| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 13.588 | 17.217 | 22.156 | 37.420 | 35.511 | 23.323 | 28.785 | 32.203 | 28.492 | 33.222 |
| Total Income - EUR | 13.604 | 17.241 | 22.299 | 37.423 | 41.870 | 23.324 | 28.818 | 32.246 | 28.513 | 33.745 |
| Total Expenses - EUR | 19.701 | 22.411 | 15.608 | 28.807 | 22.897 | 17.852 | 29.684 | 28.264 | 20.613 | 28.959 |
| Gross Profit/Loss - EUR | -6.097 | -5.170 | 6.691 | 8.616 | 18.973 | 5.472 | -866 | 3.982 | 7.900 | 4.786 |
| Net Profit/Loss - EUR | -6.505 | -5.577 | 6.405 | 8.214 | 18.572 | 5.274 | -985 | 3.703 | 7.650 | 3.795 |
| Employees | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Rusidava Intermed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 20.420 | 20.102 | 24.693 | 22.979 | 25.239 | 23.024 | 21.339 | 29.128 | 26.915 | 24.095 |
| Current Assets | 3.316 | 5.187 | 3.472 | 8.033 | 5.804 | 13.217 | 14.623 | 7.480 | 14.696 | 7.368 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 2.345 | 4.996 | 3.264 | 3.381 | 4.853 | 4.479 | 5.599 | 7.051 | 5.910 | 5.011 |
| Cash | 972 | 191 | 208 | 4.652 | 951 | 8.738 | 9.024 | 428 | 8.787 | 2.357 |
| Shareholders Funds | 7.588 | 1.934 | 8.306 | 16.367 | 30.407 | 35.105 | 33.342 | 4.783 | 12.418 | 4.866 |
| Social Capital | 135 | 134 | 131 | 129 | 126 | 124 | 121 | 122 | 121 | 121 |
| Debts | 16.149 | 23.355 | 19.859 | 14.654 | 648 | 1.136 | 2.629 | 31.838 | 29.276 | 26.657 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "5520 - 5520" | |||||||||
| CAEN Financial Year |
5590
|
|||||||||
Comments - Rusidava Intermed Srl